Skama Tek offers a unique, state-of-the-art, vaporizer that allows consumers to utilize cannabinoid concentrates on the go. Their vaporizer pen product line is portable and comes in a variety of different colors including Skama Black, Blue, Silver, and also their Camo Skama.
The Skama Tek 1.0 allows their customers to utilize 3 different temperature settings depending upon the CBD or THC concentrate they are vaping. Their variety of temperature settings helps produce a smooth and favorable vapor that keeps the integrity of the concentrates taste intact.
Their heating chamber is created out of ceramic and one of the most innovative aspects of the Skama Tek 1.0 is their patent pending portable magnetic Dab Tool that comes in tact with each unit.
Shama Tek also gives back to their customers. The company understands that cannabinoids produces a wide array of medicinal benefits and how their portable vaporizers units can help those in need. Consumption of the cannabis plant has shown to reduce the symptoms of PTSD which is why for every Shama Tek Camo unit bought by their customers, another unit will be purchased and gifted to a military veteran.
At a reasonable price point of $99.00 Skama Tek 1.0 should be considered as one of the top vaporizers on the market.
You may be interested
Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio OregonEditor - November 27, 2018
Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…
Wayland Group Enters UK Cannabis Market with Theros Pharma AcquisitionEditor - November 26, 2018
Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…
GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical TrialsEditor - November 26, 2018
GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…